There are currently 11 active clinical trials seeking participants for Osteoporosis research studies. The states with the highest number of trials for Osteoporosis participants are California, Florida, Illinois and Pennsylvania.
Skeletal Response to Simulated Night Shift
Recruiting
This small intervention study will determine if simulated short-term night shift work (NSW) negatively alters bone metabolism. The specific aim of the study is to determine if NSW acutely uncouples bone turnover markers (BTMs), if sympathetic tone is a mechanism for this disruption and if a resumption of a normal sleep/wake pattern reverses BTM uncoupling. Our hypothesis is that NSW will reversibly uncouple BTMs via increased sympathetic nervous system (SNS) tone.
Gender:
ALL
Ages:
Between 20 years and 40 years
Trial Updated:
07/25/2025
Locations: CU Anschutz, Aurora, Colorado
Conditions: Osteoporosis, Circadian Rhythm Sleep Disorder, Shift Work Type
Mode of Exercise and Bone Biomarkers in Older Veterans
Recruiting
Adults are often encouraged to exercise to maintain or improve bone health. However, there is evidence that exercise does not always lead to increases in bone mass, and exercise could lead to bone loss under certain conditions. Endurance exercise can increase bone resorption following an exercise bout, which may explain why bone does not always favorably adapt to exercise, but it is unclear if this also happens with resistance exercise. Further, it is not known how exercise training influences b... Read More
Gender:
ALL
Ages:
60 years and above
Trial Updated:
06/04/2025
Locations: Rocky Mountain Regional VA Medical Center, Aurora, CO, Aurora, Colorado
Conditions: Aging, Musculoskeletal Diseases, Osteoporosis
EffCaMgCit to Prevent Mineral Metabolism and Renal Complications of Chronic PPI Therapy
Recruiting
Proton pump inhibitors (PPIs) are widely used for the control of gastric ulcer-gastritis, erosive esophagitis (gastroesophageal reflux disease), peptic ulcer disease (duodenal ulcer), and heartburn. Despite their efficacy, their use has been implicated in possibly causing fragility fractures (osteoporosis), hypomagnesemia (magnesium deficiency) and increased risk of chronic kidney disease (CKD). The current trial represents the investigators ongoing effort to discern whether these complications... Read More
Gender:
ALL
Ages:
Between 21 years and 99 years
Trial Updated:
05/22/2025
Locations: University of Texas Southwestern Medical Center, Dallas, Texas +1 locations
Conditions: Osteoporosis, Hypomagnesemia
Combined Anabolic Therapy
Recruiting
In this research study the study investigators want to learn more about the effect of two different FDA-approved medication regimens in the treatment of postmenopausal osteoporosis.
Gender:
FEMALE
Ages:
45 years and above
Trial Updated:
03/13/2025
Locations: Massachusetts General Hospital, Boston, Massachusetts
Conditions: Osteoporosis, Postmenopausal, Osteoporosis
Preserving Geriatric Muscle With an Osteoporosis Medication
Recruiting
Our goal is to demonstrate efficacy of the novel agent Denosumab to improve or preserve muscle health, strength, mobility and function in frail older adults.
Gender:
ALL
Ages:
65 years and above
Trial Updated:
03/04/2025
Locations: St. Barnabas Woodlands, Pittsburgh, Pennsylvania
Conditions: Osteoporosis
Effect of Acetylcholinesterase Inhibitors on Bone Metabolism
Recruiting
People with Alzheimer's disease are at an increased risk of bone fracture. Some studies have shown that those taking donepezil have a lower rate of bone fractures, but the reasons for this are unknown. The purpose of this study is to measure the effect of donepezil treatment on bone metabolism factors including bone mineral density, bone turnover markers, and bone quality. Participants in this study will have a bone density test and have blood samples collected at the baseline study visit. Part... Read More
Gender:
ALL
Ages:
50 years and above
Trial Updated:
02/04/2025
Locations: Duke Memory Disorders Clinic, Durham, North Carolina
Conditions: Osteoporosis
Synbiotic to Attenuate Resorption of the Skeleton
Recruiting
This randomized, double blind, placebo controlled clinical trial will test the efficacy of a probiotic/prebiotic combination ("synbiotic") on the skeleton in older women.
Gender:
FEMALE
Ages:
60 years and above
Trial Updated:
02/04/2025
Locations: Hebrew SeniorLife, Roslindale, Massachusetts
Conditions: Osteoporosis, Inflammation, Aging
RESTORE: REducing Future FractureS and Improving OuTcOmes of FRagility FracturE
Recruiting
RESTORE tests whether Augmented-FLS, where patients are contacted by a patient navigator (serving as the liaison) and referred to a bone health provider, is better than Enhanced Usual Care, which includes patient and PCP education and activation. We also aim to determine the influence of age, race, ethnicity, sex, poverty level, geographic region, and timing of entry into the trial after a fracture on the effectiveness of the two strategies.
Gender:
ALL
Ages:
50 years and above
Trial Updated:
01/30/2025
Locations: University of Alabama at Birmingham, Birmingham, Alabama
Conditions: Osteoporosis, Osteoporotic Fractures
Surgeon-Initiated Bone Health Referral Pathway in Patients Undergoing Lower Extremity Arthroplasty
Recruiting
The goal of this clinical trial is to observe the impact of a surgeon-driven bone health referral pathway following lower extremity arthroplasty. The main question this study aims to answer is: 1) What is impact of a surgeon-driven bone health referral pathway on implant-related complications and fragility fractures when compared to standard of care primary care provider referral. Researchers will compare the endocrinology referral pathway and standard of care to see if there is a difference i... Read More
Gender:
ALL
Ages:
50 years and above
Trial Updated:
10/28/2024
Locations: Charter Professional Center, Columbia, Maryland
Conditions: Osteoporosis, Arthroplasty Complications, Fragility Fracture
Treatment With Romosozumab to Improve Bone Mineral Density and Architecture in Chronic SCI
Recruiting
The objective of the proposed work is to determine whether administration for 12 months of romosozumab (evenity) followed by 12 months of denosumab (prolia) will maintain bone mass at the knee in subjects with chronic SCI.
Gender:
All
Ages:
Between 18 years and 65 years
Trial Updated:
03/21/2024
Locations: Kessler Institute for Rehabilitation, West Orange, New Jersey +1 locations
Conditions: Osteoporosis, Spinal Cord Injuries
PatientSpot Formerly Known as ArthritisPower
Recruiting
Patient Power is a patient research network and database (registry) to collect prospective information about demographics, self-reported diagnoses and medications, and willingness to participate in research from participants with rheumatoid arthritis (RA), spondyloarthritis (SpA), other musculoskeletal conditions, chronic neurological conditions like migraine, chronic pulmonary conditions like Chronic Obstructive Pulmonary Disease (COPD), asthma, autoimmune dermatological conditions such as psor... Read More
Gender:
ALL
Ages:
19 years and above
Trial Updated:
12/12/2023
Locations: Global Healthy Living Foundation, Upper Nyack, New York
Conditions: Rheumatoid Arthritis, Ankylosing Spondylitis, Fibromyalgia, Gout, Crohn Disease, Juvenile Idiopathic Arthritis, Lupus Erythematosus, Myositis, Osteoarthritis, Osteoporosis, Psoriasis, Psoriatic Arthritis, Scleroderma, Dermatomyositis, Inflammatory Bowel Diseases, Polymyositis, Axial Spondyloarthritis, Diffuse Idiopathic Skeletal Hyperostosis, Polymyalgia Rheumatica, Giant Cell Arteritis, Temporal Arteritis, Wegener, Relapsing Polychondritis, Undifferentiated Connective Tissue Disease, Spinal Cord Injuries, Alzheimer Disease, Amyotrophic Lateral Sclerosis, Ataxia, Bell Palsy, Brain Tumor, Cerebral Aneurysm, Epilepsy, Guillain-Barre Syndrome, Headache, Head Injury, Hydrocephalus, Lumbar Disc Disease, Meningitis, Multiple Sclerosis, Muscular Dystrophy, Neurocutaneous Syndromes, Parkinson Disease, Stroke, Cluster Headache, Tension-Type Headache, Chronic Obstructive Pulmonary Disease, Asthma, Lung Cancer, Cystic Fibrosis, Sleep Apnea, Eczema, Alopecia, Chronic Inflammation, Unstable Angina, Heart Attack, Heart Failure, Arrythmia, Valve Heart Disease, High Blood Pressure, Congenital Heart Disease, Peripheral Arterial Disease, Diabetes, Chronic Liver Disease, Obesity